CPSH
CPS Technologies Corporation
CPSH trails on the overall score without a compensating advantage in the available component scores.
MU
Micron Technology, Inc.
MU has the edge over CPSH overall, supported by stronger fundamentals and stronger valuation.
CPSH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Weak | |
| Strong |
CPSH's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is weak.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CPSH PE Valuation
CPSH has no meaningful PE right now: it lost money over the past year.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
CPSH Forward outlook
There aren't enough analyst estimates for CPSH to show an outlook.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
CPSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.00 | +$0.04 |
| Q2 2026 | -$0.01 | +$0.11 |
| Q1 2026 | $0.00 | +$0.20 |
| Q4 2025 | $0.03 | +$0.25 |
| Q3 2025 | -$0.04 | +$0.10 |
| Q2 2025 | -$0.12 | -$0.06 |
| Q1 2025 | -$0.20 | -500% |
| Q4 2024 | -$0.22 | -344% |
CPSH is still losing money, but far less than before: $0.00 per share over the past year, against $0.22 at its worst in late 2024.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CPSH on earnings, with more consistent year-over-year improvement.
CPSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +1.1% |
| Q2 2026 | $8.3M | +2.9% |
| Q1 2026 | $7M | -6.4% |
| Q4 2025 | $8.2M | +38% |
| Q3 2025 | $8.8M | +107% |
| Q2 2025 | $8.1M | +61% |
| Q1 2025 | $7.5M | +27% |
| Q4 2024 | $5.9M | -12% |
CPSH's revenue is growing: $9M last quarter, up 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4% | +0.9 points |
| Q2 2026 | -3.1% | -4.8 points |
| Q1 2026 | -7.4% | -9.2 points |
| Q4 2025 | -1.2% | +21 points |
| Q3 2025 | 3.1% | +38 points |
| Q2 2025 | 1.7% | +28 points |
| Q1 2025 | 1.7% | +6.1 points |
| Q4 2024 | -22% | -24 points |
CPSH's operating margin was 4% last quarter, up 0.9 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CPSH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CPSH on profitability, with a higher operating margin.
CPSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$310.2K | -135% |
| Q2 2026 | -$2.4M | -601% |
| Q1 2026 | -$767.8K | +$578K |
| Q4 2025 | -$494.4K | +$974.6K |
| Q3 2025 | $876.8K | +$2.1M |
| Q2 2025 | $476.4K | +$2.1M |
| Q1 2025 | -$1.3M | -$1.2M |
| Q4 2024 | -$1.5M | -3294% |
CPSH has burned cash in six of the last eight quarters: −$4M over the past year, against −$1M the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over CPSH on cash generation, producing positive trailing cash flow while its opponent burns cash.
CPSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.8% | +903K shares |
| 1 year | +35% | +5.1M shares |
| 3 years | +35% | +5.1M shares |
| 5 years | +33% | +4.9M shares |
| Available history | +50% | +6.6M shares |
CPSH has 20M diluted shares, up 35% from a year ago.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has the edge over CPSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
CPSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -36.2x | Net Cash |
| Q1 2026 | -15.1x | Net Cash |
| Q4 2025 | -4.3x | Net Cash |
| Q1 2024 | -7.1x | Net Cash |
| Q4 2023 | -4.0x | Net Cash |
| Q3 2023 | -3.7x | Net Cash |
| Q2 2023 | -2.9x | Net Cash |
| Q1 2023 | -2.6x | Net Cash |
CPSH has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CPSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.8 | Neutral |
| Stochastic | 36.9 | Neutral |
CPSH's weekly RSI is 49 (neutral) and its Stochastic is 37 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CPSH PE vs Technology Sector
| Metric | CPSH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CPSH has no meaningful PE right now: it lost money over the past year.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.
CPSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.72 | 10% above |
| 20 week MA | $4.04 | 1.5% above |
| 50 week MA | $4.51 | 9.1% below |
| 100 week MA | $3.52 | 16% above |
| 200 week MA | $2.89 | 42% above |
CPSH has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
CPSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.05 | $2.29 | +118% |
| 2021 | $2.29 | $4.34 | +90% |
| 2022 | $4.34 | $2.75 | -37% |
| 2023 | $2.75 | $2.35 | -15% |
| 2024 | $2.35 | $1.62 | -31% |
| 2025 | $1.62 | $3.21 | +98% |
| 2026 YTD | $3.21 | $4.10 | +28% |
CPSH has finished lower in three of the last six years. It's up 28% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CPSH on returns for 2026, with the stronger performance.